Combined intraepidermal neuroendocrine (Merkel cell) and squamous cell carcinoma in situ with CM2B4 negativity and p53 overexpression(*). uri icon

Overview

abstract

  • Primary cutaneous neuroendocrine carcinoma, also known as Merkel cell carcinoma (MCC), usually presents as a dermal and/or subcutaneous tumor. Rarely, it is confined to the epidermis or adnexal epithelium [MCC in situ (MCCIS)]. Little is known about the spectrum of features and biology of MCCIS. Herein, we report a case of MCCIS arising on the cheek of a 77-year-old Caucasian male, which was associated with squamous cell carcinoma in situ. The tumor cells of both the neuroendocrine and squamous components prominently involved adnexal structures but did not invade the dermis. The tumor cells with neuroendocrine features were immunoreactive for cytokeratin-20, chromogranin and synaptophysin. They also expressed p53 but were non-reactive with the monoclonal antibody CM2B4. Lack of labeling for CM2B4 is in keeping with prior observations of combined squamous and MCC. Our findings support the concept of a distinct subtype of virus-independent cutaneous neuroendocrine carcinoma that differs from conventional MCC. The observed overexpression of p53 suggests that the development of this tumor type may be related to chronic ultraviolet damage.

publication date

  • April 24, 2012

Research

keywords

  • Carcinoma, Merkel Cell
  • Carcinoma, Squamous Cell
  • Gene Expression Regulation, Neoplastic
  • Neoplasms, Second Primary
  • Skin Neoplasms
  • Tumor Suppressor Protein p53

Identity

Scopus Document Identifier

  • 84861648032

Digital Object Identifier (DOI)

  • 10.1111/j.1600-0560.2012.01908.x

PubMed ID

  • 22524588

Additional Document Info

volume

  • 39

issue

  • 6